← back to search

Denis Talbot

Centre hospitalier universitaire de Québec · CA
Area of research
Statistics and Probability · General Health Professions
Research interest
Research interests include Advanced Causal Inference Techniques, Workplace Health and Well-being, SARS-CoV-2 and COVID-19 Research, and Lung Cancer Treatments and Mutations.
h-index
44
citations
7,254
works
309
NIH funding
primary concept
Medicine
email

Recent publications

Adaptive Sparsening and Smoothing of the Treatment Model for Longitudinal Causal Inference Using Outcome-Adaptive LASSO and Marginal Fused LASSO.
2026cited by 1position: contributordoi
Effectiveness of COVID-19 Vaccination and Prior Infections to Reduce Long COVID Risk During the Pre-Omicron and Omicron Periods.
2026cited by 0position: contributordoi
Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.
2026cited by 0position: contributordoi
Functional impact of long COVID among healthcare workers with comorbidities in Quebec, Canada: a cross-sectional study.
2026cited by 0position: contributordoi
Incidence and predictors of problem gambling in first-episode psychosis: A prospective multicentre cohort study.
2026cited by 0position: contributordoi
Polypharmacy as a Simple Measure for Assessing the Risk of Fall-Related Hospitalization in Older Adults
American Journal of Preventive Medicine 2026cited by 0position: contributordoi
Incidence of Physician-Diagnosed Depression Attributable to Psychosocial Stressors at Work
2026cited by 0position: contributordoi
2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada
2026cited by 0position: contributordoi
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada
The Lancet Regional Health - Americas 2026cited by 0position: contributordoi
Potential biases in test-negative design studies of COVID-19 vaccine effectiveness arising from the inclusion of asymptomatic individuals.
2025cited by 7position: contributordoi
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up.
2025cited by 5position: contributordoi
Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology-endorsed systematic review of methodology.
2025cited by 4position: contributordoi
A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Analysis of Québec Administrative Data.
2025cited by 3position: contributordoi
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time‐To‐Event Outcomes
Statistics in Medicine 2025cited by 2position: firstdoi
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes in preterm, high-risk and healthy-term infants, Quebec, Canada
2025cited by 2position: contributordoi
Coronary Heart Disease Attributable to Psychosocial Stressors at Work
JACC Advances 2025cited by 1position: middledoi
Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network.
2025cited by 1position: contributordoi
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed Guidance.
2025cited by 1position: contributordoi
Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time-To-Event Outcomes.
2025cited by 1position: contributordoi
An examination of acrylamide and cadmium as possible mediators of the association between cigarette smoking and chronic musculoskeletal pain.
2025cited by 1position: contributordoi
Using Machine Learning to Improve Control for Confounding in the Dynamic Weighted Ordinary Least Squares Estimator of Optimal Adaptive Treatment Strategies.
2025cited by 0position: contributordoi
The Authors Respond.
2025cited by 0position: contributordoi
Repeated exposure to psychosocial work-related factors and arterial stiffness among aging workers.
2025cited by 0position: contributordoi
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods
2025cited by 0position: contributordoi
Reply to Zeng and Zhou.
2025cited by 0position: contributordoi
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
2024cited by 19position: contributordoi
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review.
2024cited by 11position: contributordoi
Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.
2024cited by 6position: contributordoi
Impact of Educational Activity Formats, Online or In-Person, on the Intention of Medical Specialists to Adopt a Clinical Behaviour: A Comparative Study.
2024cited by 5position: contributordoi
Psychosocial Stressors at Work and Atrial Fibrillation Incidence: An 18-Year Prospective Study.
2024cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 58 papers (2019–2026) · 14 papers (2021–2026)Gaston De Serres · Centre hospitalier universitaire de Québec9 papers (2021–2026) · 9 papers (2022–2026) · 9 papers (2021–2026)Danielle Laurin · Centres Intégré Universitaires de Santé et de Services Sociaux8 papers (2019–2025)Neil Pearce · Faculty of Public Health7 papers (2019–2025)Mireille E. Schnitzer · BMJ Publishing Group7 papers (2022–2026)Danuta M. Skowronski · Simon Fraser University6 papers (2022–2026) · 6 papers (2022–2026) · 6 papers (2022–2026)Miceline Mésidor · Institut National de la Recherche Scientifique5 papers (2023–2024)Manale Ouakki · Institut National de Santé Publique du Québec5 papers (2022–2026)Xavier Trudel · The Quebec Population Health Research Network5 papers (2021–2026)Caroline Sirois · American Pharmacists Association5 papers (2023–2025)Chantal Brisson · Université Laval4 papers (2019–2025)Alain Milot · Université Laval4 papers (2019–2025)Xavier Trudel · Université Laval4 papers (2019–2025)Caroline Diorio · Université Laval4 papers (2023–2025)Mahée Gilbert-Ouimet · Université Laval4 papers (2021–2026)